European Legislators Want Stricter Disclosure Laws

08/15/2002 | Financial Times (free content)

The European Agency for the Evaluation of Medicines, which is equivalent to the U.S.' FDA, is planning to ask drug companies to submit data on their products, including those that failed to gain regulatory approval. But the drug industry says the planned disclosure law could mar commercial prospects.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX